Article
Monitoring of First-line Drug Resistance Mutations Outside the Scope of Xpert MTB/RIF Ultra is Needed for Successful Control of DR-TB in Southern Mozambique.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 10 Apr 2024
Mariner-Llicer Carla, Saavedra Cervera Belén, Mambuque Edson, Gomes Neide, Munguambe Shilzia, Villamayor Luis, Cancino-Muñoz Irving, Torres-Puente Manuela, Nguenha Dinis, Respeito Durval, Tembe Gustavo, López Mariana G, Comas Iñaki, García-Basteiro Alberto L
Abstract excerpt
Multidrug-resistant(MDR) tuberculosis in Southern Africa is of great concern, exacerbated by the spread of a clone harboring a mutation missed by Xpert Ultra. In Southern Mozambique, the presence of such mutation and rising cases of non-MDR isoniazid resistance highlights the need to ensure accurate detection of antimicrobial-resistance in the country.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
